Bio Blast Pharma Company Profile (NASDAQ:ORPN)

About Bio Blast Pharma

Bio Blast Pharma logoBio Blast Pharma Ltd. (BioBlast) is a development-stage biopharmaceutical company. The Company is focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases. It focuses on therapeutic platforms that offer solutions for several diseases that share a common pathophysiological mechanism, which are the functional changes that accompany a particular syndrome or disease. It also focuses on diseases with severe and debilitating manifestations. The Company has several drug candidates in clinical or preclinical development targeting neuromuscular/central nervous system (CNS) and mitochondrial diseases. Its drug candidates include Trehalose IV Solution, BB-FA (Bioblast-Friedreich's ataxia) and BBrm-02. The Company's product candidate platforms include Protein Stabilizing Platform, Read-through Platform and Mitochondrial Protein Replacement Platform.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ORPN
  • CUSIP:
Key Metrics:
  • Previous Close: $1.66
  • 50 Day Moving Average: $1.69
  • 200 Day Moving Average: $2.15
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.69
  • P/E Growth: 0.00
  • Market Cap: $27.21M
  • Outstanding Shares: 16,391,000
  • Beta: 0.09
Additional Links:
Companies Related to Bio Blast Pharma:

Analyst Ratings

Consensus Ratings for Bio Blast Pharma (NASDAQ:ORPN) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $23.75 (1,330.72% upside)

Analysts' Ratings History for Bio Blast Pharma (NASDAQ:ORPN)
Show:
DateFirmActionRatingPrice TargetDetails
8/26/2016Roth CapitalReiterated RatingBuy$15.00View Rating Details
7/11/2016Rodman & RenshawReiterated RatingBuyView Rating Details
1/28/2016HC WainwrightInitiated CoverageBuy$25.00View Rating Details
11/27/2015Oppenheimer Holdings Inc.Reiterated RatingOutperform$32.00View Rating Details
(Data available from 8/29/2014 forward)

Earnings

Earnings History for Bio Blast Pharma (NASDAQ:ORPN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/15/2016        
8/25/2016Q2($0.27)($0.22)ViewN/AView Earnings Details
5/25/2016Q1($0.29)($0.32)ViewN/AView Earnings Details
2/23/2016Q4($0.25)($0.34)ViewN/AView Earnings Details
11/17/2015Q3($0.29)($0.25)ViewN/AView Earnings Details
8/21/2015Q2($0.28)($0.26)ViewN/AView Earnings Details
5/19/2015Q115($0.25)($0.23)ViewN/AView Earnings Details
2/17/2015Q414($0.16)($0.22)ViewN/AView Earnings Details
11/21/2014($0.09)($0.16)ViewN/AView Earnings Details
8/29/2014Q214($0.09)($0.10)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Bio Blast Pharma (NASDAQ:ORPN)
Current Year EPS Consensus Estimate: $-1.03 EPS
Next Year EPS Consensus Estimate: $-0.98 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.33)($0.26)($0.30)
Q2 20161($0.33)($0.33)($0.33)
Q3 20161($0.22)($0.22)($0.22)
Q4 20161($0.23)($0.23)($0.23)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Bio Blast Pharma (NASDAQ:ORPN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Bio Blast Pharma (NASDAQ:ORPN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Bio Blast Pharma (NASDAQ:ORPN)
DateHeadline
investornewswire.com logoCan Shares Of Bio Blast Pharma Ltd. (NASDAQ:ORPN) Get To $19? - Investor Newswire (NASDAQ:ORPN)
www.investornewswire.com - August 29 at 6:27 PM
finance.yahoo.com logoBioblast Pharma Reports Second Quarter 2016 Financial Results - Yahoo Finance (NASDAQ:ORPN)
finance.yahoo.com - August 26 at 9:41 AM
seekingalpha.com logoBio Blast Pharma reports Q2 results (NASDAQ:ORPN)
seekingalpha.com - August 25 at 11:48 AM
sg.finance.yahoo.com logoBio Blast reports 2Q loss (NASDAQ:ORPN)
sg.finance.yahoo.com - August 25 at 11:48 AM
investornewswire.com logoBio Blast Pharma Ltd. (NASDAQ:ORPN) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:ORPN)
www.investornewswire.com - August 22 at 6:39 PM
investornewswire.com logoWill Bio Blast Pharma Ltd. (NASDAQ:ORPN) Hit $19 Price Target? - Investor Newswire (NASDAQ:ORPN)
www.investornewswire.com - August 16 at 6:49 PM
ftsenews.co.uk logoBio Blast Pharma Ltd. (ORPN) Updated Price Targets - FTSE News ... - FTSE News (NASDAQ:ORPN)
www.ftsenews.co.uk - August 2 at 6:59 PM
News IconTrending Stock Analysis: Bio Blast Pharma Ltd. (NASDAQ:ORPN) - News Oracle (NASDAQ:ORPN)
www.newsoracle.com - July 26 at 9:56 AM
investornewswire.com logoCan Shares Of Bio Blast Pharma Ltd. (NASDAQ:ORPN) Hit $19? - Investor Newswire (NASDAQ:ORPN)
www.investornewswire.com - July 25 at 6:51 PM
News IconChecking in on Stock Volatility for: Bio Blast Pharma Ltd. (NASDAQ:ORPN) - Engelwood Daily (NASDAQ:ORPN)
www.engelwooddaily.com - July 21 at 7:00 PM
fiscalstandard.com logoBroker Outlook For Bio Blast Pharma Ltd. (ORPN) - Fiscal Standard (NASDAQ:ORPN)
www.fiscalstandard.com - July 21 at 7:00 PM
kcregister.com logoTop Stories: Bio Blast Pharma (NASDAQ:ORPN), Neptune Technologies & Bioressources (NASDAQ:NEPT), Ellington ... - KC Register (NASDAQ:ORPN)
www.kcregister.com - July 19 at 7:36 AM
fiscalstandard.com logoNext Weeks Broker Price Targets For Bio Blast Pharma Ltd. (ORPN) - Fiscal Standard (NASDAQ:ORPN)
www.fiscalstandard.com - July 19 at 7:36 AM
investornewswire.com logoIs $19 Price Target Attainable For Bio Blast Pharma Ltd. (NASDAQ:ORPN)? - Investor Newswire (NASDAQ:ORPN)
www.investornewswire.com - July 19 at 7:36 AM
News IconWere Analysts Bearish Bio Blast Pharma Ltd (NASDAQ:ORPN) This Week? - Press Telegraph (NASDAQ:ORPN)
presstelegraph.com - July 19 at 7:36 AM
News IconShares Moving Down on the Week: Bio Blast Pharma Ltd. (NASDAQ:ORPN) - Engelwood Daily (NASDAQ:ORPN)
www.engelwooddaily.com - July 16 at 6:12 PM
investornewswire.com logoStrong Sell Calls For Bio Blast Pharma Ltd. (NASDAQ:ORPN) At 0 - Investor Newswire (NASDAQ:ORPN)
www.investornewswire.com - July 12 at 6:57 PM
news.cmlviz.com logoBio Blast Pharma Ltd. Stock Momentum Hits Extreme Weakness - CML News (NASDAQ:ORPN)
news.cmlviz.com - July 11 at 6:41 PM
News IconHow Many Bio Blast Pharma Ltd (NASDAQ:ORPN)'s Analysts Are Bullish? - Consumer Eagle (NASDAQ:ORPN)
www.consumereagle.com - July 11 at 6:41 PM
fiscalstandard.com logoBroker Outlook For The Week Ahead Bio Blast Pharma Ltd. (ORPN) - Fiscal Standard (NASDAQ:ORPN)
www.fiscalstandard.com - July 5 at 11:10 AM
finance.yahoo.com logoTesaro (TSRO) in Focus: Stock Adds 8.6% in Session (NASDAQ:ORPN)
finance.yahoo.com - July 1 at 8:29 AM
ftsenews.co.uk logoBio Blast Pharma Ltd. (ORPN) Updated Price Targets - FTSE News (NASDAQ:ORPN)
www.ftsenews.co.uk - June 30 at 6:58 PM
finance.yahoo.com logoCalithera Biosciences (CALA) Jumps: Stock Rises 7.6% (NASDAQ:ORPN)
finance.yahoo.com - June 29 at 8:30 AM
investornewswire.com logoStrong Sell Calls Recommendations For Bio Blast Pharma Ltd. (NASDAQ:ORPN) At 0 - Investor Newswire (NASDAQ:ORPN)
www.investornewswire.com - June 27 at 6:39 PM
News IconAre Analysts Bearish Bio Blast Pharma Ltd (NASDAQ:ORPN) After Last Week? - Engelwood Daily (NASDAQ:ORPN)
www.engelwooddaily.com - June 27 at 10:50 AM
finance.yahoo.com logoRetrophin (RTRX) RE-024 Positive in Physician-Initiated Study (NASDAQ:ORPN)
finance.yahoo.com - June 24 at 9:15 AM
finance.yahoo.com logoArQule (ARQL) Shows Strength: Stock Adds 8% in Session (NASDAQ:ORPN)
finance.yahoo.com - June 23 at 8:25 AM
investornewswire.com logoStrong Buy Calls Count For Bio Blast Pharma Ltd. (NASDAQ:ORPN) At 2 - Investor Newswire (NASDAQ:ORPN)
www.investornewswire.com - June 20 at 6:30 PM
fiscalstandard.com logoThis Weeks Broker Views For Bio Blast Pharma Ltd. (ORPN) - Fiscal Standard (NASDAQ:ORPN)
www.fiscalstandard.com - June 20 at 8:17 AM
fiscalstandard.com logoBio Blast Pharma Ltd. (ORPN) Current Analyst Ratings - Fiscal Standard (NASDAQ:ORPN)
www.fiscalstandard.com - June 16 at 10:52 AM
finance.yahoo.com logoShould You Get Rid of Valeant Pharmaceuticals (VRX) Now? (NASDAQ:ORPN)
finance.yahoo.com - June 16 at 8:31 AM
kcregister.com logoResolute Forest Products Inc. (NYSE:RFP) plummeted -6.48%: Bio Blast Pharma Ltd. (NASDAQ:ORPN), Avnet, Inc ... - KC Register (NASDAQ:ORPN)
www.kcregister.com - June 14 at 6:24 PM
zacks.com logoZafgen (ZFGN) Presents Favorable New Data on Beloranib (NASDAQ:ORPN)
www.zacks.com - June 13 at 6:15 PM
zacks.com logoNew Strong Buy Stocks for June 13th (NASDAQ:ORPN)
www.zacks.com - June 13 at 9:38 AM
streetinsider.com logoBioBlast Pharma (ORPN) Plans Trehalose IV Phase 2b in OPMD; Will Evaluate in Other Orphan Diseases - StreetInsider.com (NASDAQ:ORPN)
www.streetinsider.com - June 9 at 9:39 AM
finance.yahoo.com logo6:02 am Bio Blast Pharma announces plans to initiate a Phase 2b trial with trehalose IV solution in OPMD during the second half of 2016, CFO to leave the co, CEO Colin Foster leaves position but remains on the Board, Executive Chairman Fred (NASDAQ:ORPN)
finance.yahoo.com - June 9 at 6:02 AM
finance.yahoo.com logoBioblast Pharma Updates Corporate Plans (NASDAQ:ORPN)
finance.yahoo.com - June 9 at 6:00 AM
kcregister.com logoNokia Corporation (ADR) (NYSE:NOK) increased 0.53%: Bio Blast Pharma Ltd. (NASDAQ:ORPN), IdaCorp, Inc. (NYSE ... - KC Register (NASDAQ:ORPN)
www.kcregister.com - June 6 at 10:22 AM
kcregister.com logoMakeMyTrip Limited (NASDAQ:MMYT) decreased -2.35%: Bio Blast Pharma Ltd. (NASDAQ:ORPN), Pacira ... - KC Register (NASDAQ:ORPN)
www.kcregister.com - June 6 at 10:22 AM
investopedia.com logo5 Stocks Under $5 With Potential (SIRI,GRPN,KTOS) (NASDAQ:ORPN)
www.investopedia.com - June 2 at 11:18 AM
News IconAnalysts Expect Bio Blast Pharma Ltd (NASDAQ:ORPN) to Post ($0.29) EPS - Let Me Know About This (NASDAQ:ORPN)
www.lmkat.com - May 31 at 1:17 AM
News IconNext Weeks Broker Price Targets For Bio Blast Pharma Ltd. (ORPN) - Share Trading News (NASDAQ:ORPN)
www.sharetrading.news - May 30 at 6:46 PM
News IconNext Weeks Broker Price Targets For Bio Blast Pharma Ltd. (ORPN) - Share Trading News (NASDAQ:ORPN)
www.sharetrading.news - May 30 at 6:46 PM
finance.yahoo.com logoBio Blast Pharma (ORPN) in Focus: Stock Moves Up 54.5% (NASDAQ:ORPN)
finance.yahoo.com - March 17 at 8:15 AM
finance.yahoo.com logoBio Blast Pharma (ORPN) in Focus: Stock Moves Up 54.5% (NASDAQ:ORPN)
finance.yahoo.com - March 17 at 8:15 AM
finance.yahoo.com logoBioBlast Pharma Announces Pricing of $6.7 Million Registered Direct Offering (NASDAQ:ORPN)
finance.yahoo.com - March 17 at 7:00 AM
finance.yahoo.com logoBioBlast Pharma Announces Pricing of $6.7 Million Registered Direct Offering (NASDAQ:ORPN)
finance.yahoo.com - March 17 at 7:00 AM
insidermonkey.com logoWhy Oracle (ORCL), Celator Pharma (CPXX), Peabody Energy (BTU) and Others Are Trending Today (NASDAQ:ORPN)
www.insidermonkey.com - March 16 at 3:18 PM
insidermonkey.com logoWhy Oracle (ORCL), Celator Pharma (CPXX), Peabody Energy (BTU) and Others Are Trending Today (NASDAQ:ORPN)
www.insidermonkey.com - March 16 at 3:18 PM
247wallst.com logoBio Blast Pharma Explodes on Positive Results (NASDAQ:ORPN)
247wallst.com - March 16 at 10:45 AM

Social

Bio Blast Pharma (NASDAQ:ORPN) Chart for Monday, August, 29, 2016


Last Updated on 8/29/2016 by MarketBeat.com Staff